| scholarly article | Q13442814 |
| P2093 | author name string | Jun Wang | |
| Jing He | |||
| Haidong Zhou | |||
| Changshun Huang | |||
| Weifei Wang | |||
| Jungang Zheng | |||
| Linhai Zhu | |||
| Saihong Cai | |||
| Xinger Qian | |||
| Zihui Lu | |||
| P2860 | cites work | Association of high-dose postoperative opioids with recurrence risk in esophageal squamous cell carcinoma: reinterpreting ERAS protocols for long-term oncologic surgery outcomes | Q50243586 |
| Opioids have no negative effect on the survival time of patients with advanced lung cancer in an acute care hospital. | Q51669750 | ||
| Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? | Q53558050 | ||
| Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma. | Q53681071 | ||
| Validation of the Polish version of the Critical Care Pain Observation Tool (CPOT) to assess pain intensity in adult, intubated intensive care unit patients: the POL-CPOT study. | Q55654731 | ||
| Validation of the behavioral pain scale to assess pain intensity in adult, intubated postcardiac surgery patients: A cohort observational study - POL-BPS | Q58704269 | ||
| Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223 | Q60301691 | ||
| Opioids, survival, and advanced cancer in the hospice setting | Q83296134 | ||
| How to obtain the confidence interval from a P value | Q84718580 | ||
| Pain management for patients with cancer | Q88230149 | ||
| Opioid Dose and Survival of Patients with Incurable Nonsmall Cell Lung Cancer: A Prospective Cohort Study | Q89075203 | ||
| Cancer treatment and survivorship statistics, 2019 | Q92655901 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 | ||
| Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors | Q33409603 | ||
| A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection | Q35000444 | ||
| Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer | Q35011905 | ||
| Opioids and breast cancer recurrence: A Danish population-based cohort study | Q36074292 | ||
| Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients | Q36194004 | ||
| The association between different opioid doses and the survival of advanced cancer patients receiving palliative care | Q36200195 | ||
| A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide | Q36302851 | ||
| Prevalence of pain in patients with cancer: a systematic review of the past 40 years | Q36758835 | ||
| Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer. | Q37590738 | ||
| Treatment Considerations for Cancer Pain: A Global Perspective | Q38282157 | ||
| Prognostic significance of opioid use in the active treatment of advanced colorectal cancer | Q38292435 | ||
| The use of opioids at the end-of-life and the survival of Egyptian palliative care patients with advanced cancer. | Q38405145 | ||
| The mu opioid receptor: A new target for cancer therapy? | Q38515846 | ||
| Methods of pain assessment in adult intensive care unit patients - Polish version of the CPOT (Critical Care Pain Observation Tool) and BPS (Behavioral Pain Scale). | Q39210701 | ||
| Equianalgesic dosing: principles of practice for the care team | Q39233181 | ||
| Intraoperative Fentanyl Consumption Does Not Impact Cancer Recurrence or Overall Survival after Curative Colorectal Cancer Resection. | Q40052118 | ||
| Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. | Q40090587 | ||
| Use of opioid analgesics or sleeping medication and survival of cancer patients | Q41633026 | ||
| The role of morphine in animal models of human cancer: does morphine promote or inhibit the tumor growth? | Q42605590 | ||
| Opioid use at the end of life and survival in a Hospital at Home unit | Q42924062 | ||
| Independent predictors of survival in patients with incurable malignant gastric outlet obstruction: a multicenter prospective observational study | Q43066576 | ||
| The impact of intraoperative opioid use on survival after oral cancer surgery | Q43075594 | ||
| Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis | Q43076968 | ||
| Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer. | Q44345808 | ||
| Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens | Q44346721 | ||
| Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer | Q44347717 | ||
| Overall survival: patient outcome, therapeutic objective, clinical trial end point, or public health measure? | Q44874881 | ||
| Factors associated with improved survival after resection of pancreatic adenocarcinoma: a multivariable model | Q46531030 | ||
| A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis | Q46920684 | ||
| Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. | Q47653180 | ||
| Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies. | Q48112418 | ||
| Long-Term Oncologic Outcomes, Opioid Use, and Complications after Esophageal Cancer Surgery | Q49804327 | ||
| Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy | Q50017749 | ||
| P433 | issue | 9 | |
| P921 | main subject | population-based cohort study | Q108562148 |
| P304 | page(s) | e19306 | |
| P577 | publication date | 2020-02-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | The impact of pain and opioids use on survival in cancer patients: Results from a population-based cohort study and a meta-analysis | |
| P478 | volume | 99 |
Search more.